Loading...
Not a good buy right now. WSFS is in a strong uptrend, but it’s stretched/overbought (RSI~83) and sitting near key resistance (R2 ~66.04) after a post-earnings move. With no Intellectia “strong buy” signals today and short-horizon pattern stats skewing slightly negative, the risk/reward for an impatient entry is unattractive at ~64.71. I would hold/avoid buying at this level and only consider buying on a quick dip back toward the low-60s support zone.
Trend is bullish: SMA_5 > SMA_20 > SMA_200 and MACD histogram is positive and expanding (0.825), confirming upside momentum. However, RSI_6 at 83 signals a near-term overbought condition where pullbacks/consolidation are common. Price is above R1 (63.87) and pressing toward R2 (~66.04), implying upside is nearer resistance than support; first meaningful support/pivot is ~60.36.
Intellectia Proprietary Trading Signals
Short-horizon pattern model also leans mildly bearish: ~60% chance of -0.39% next day, -0.92% next week, -2.3% next month—consistent with “extended” technicals.

Dividend declared ($0.17 quarterly) and commentary/analysts highlight buybacks and improving loan/deposit momentum—supportive for the stock.
with limited immediate upside runway. No notable hedge fund/insider accumulation trends cited. Options data is thin in volume, limiting confidence in sentiment read. No congress trading catalyst (none reported).
Latest quarter: 2025/Q4. Growth trends were positive: revenue $243.668M (+2.94% YoY), net income $72.678M (+13.20% YoY), EPS $1.34 (+22.94% YoY). News also frames Q4 as a strong finish with momentum into 2026 (wealth/trust strength, capital return via buybacks), reinforcing improving profitability/earnings trajectory.
Recent analyst trend is clearly improving: multiple price target raises after Q4 results (Piper $62→$67 Neutral; KBW $63→$70 Market Perform; Stephens $66→$71 Overweight; TD Cowen $67→$73 Buy). Wall Street “pros” case: accelerating loan/deposit trends, well-managed credit, strong PPNR, and heavy capital return/buybacks with continued momentum into 2026. “Cons” case: some firms remain Neutral/Market Perform, implying upside may be more limited from here after the run; near-term entry risk is higher given the stock’s stretched technicals.